Starpharma Holdings Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of SPHRY for the last semiannual is 4.70 M USD, and it's 275.13% higher compared to the previous semiannual. The net income of H1 24 is -674.65 k USD.